Professional programs
May 4, 2010
CONTRARY to earlier speculation,
there are “significantly more funds
for professional programs” under
the Fifth Community Pharmacy
Agreement, according to Guild
President Kos Sclavos.
A range of Medication
Management programs are
included, including a new
Medicines Use Reviews (MUR)
offering which will provide an inpharmacy
medicine review between
patients and pharmacists “to
enhance the quality use of
medicines and reduce the number
of adverse medicines events”.
Initially a pilot MUR scheme will
be conducted before a national
rollout, envisaged for 2013/14.
The existing Home Medicines
Review program will also continue
under the agreement, with increased
funding, but will be modified to
focus on patients deemed at most
risk of medication misadventure.
However the MMR Facilitator
Program won’t continue under the
fifth agreement, and HMR
Accreditation Incentives will also
cease to be funded from 30 Jun.
Increased funding has been
provided for Residential Medication
Management (RMMR) under the
pact, but the program will also be
modified “with particular emphasis
on funding best practice reviews”.
And a new Diabetes Medication
Management Service will be
delivered to patients with type 2
diabetes, with the availability of the
service directed to pharmacies in
areas where other diabetes services
aren’t adequate to meet the needs
of the local population.
The Dose Administration Aids
scheme will be expanded to provide
funding to pharmacies for “meeting
certain performance requirements
concerning patient eligibility and
compliance arrangements.”
The 5CPA will also see the
cessation of the Pharmacy Asthma
Management Service.
The above article was sent to subscribers in Pharmacy Daily's issue from 04 May 10To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 May 10
